LWM Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AWA
LWM Advisory Services's BMY Position: Q4 2022 in Review
LWM Advisory Services sold out of Bristol-Myers Squibb (BMY) in Q4 2022, closing a stake of 3,234 shares — an estimated $230K sold.
LWM Advisory Services first reported a position in BMY in Q2 2022 and held it in 2 quarters. The position peaked at $230K in Q3 2022. 2,601 funds tracked by Wall St. Rank hold BMY as of Q4 2022.
- LWM Advisory Services reported no remaining Bristol-Myers Squibb position as of Q4 2022 after selling out during the quarter.
- LWM Advisory Services sold 3,234 Bristol-Myers Squibb shares in Q4 2022, an estimated $230K.
- LWM Advisory Services first reported a position in Bristol-Myers Squibb in Q2 2022 and held it in 2 quarters.
- LWM Advisory Services's Bristol-Myers Squibb position peaked at $230K in Q3 2022.
- 2,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.
Based on LWM Advisory Services's 13F filing for Q4 2022, filed 7 Feb 2023.